Download Citation
Article Source:
Comparison of the adverse event profiles of conventional and liposomal formulations of doxorubicin using the FDA adverse event reporting system
Fukuda A,
Tahara K,
Hane Y,
Matsui T,
Sasaoka S,
et al.
(2017)
Comparison of the adverse event profiles of conventional and liposomal formulations of doxorubicin using the FDA adverse event reporting system.
PLOS ONE 12(9): e0185654.
https://doi.org/10.1371/journal.pone.0185654